TABLE 3.
Continue Use at 6 Months | Continued Use at 1 Year | Time to Discontinue GER Medicationsa | ||||
---|---|---|---|---|---|---|
(n = 607) | (n = 322) | (n = 812) | ||||
aOR (95% CI) | P | aOR (95% CI) | P | HR (95% CI) | P | |
Gestational age category (wk) | ||||||
<28 | 6.91 (2.18–21.86) | .001 | 3.11 (1.65–5.85) | .000 | 0.50 (0.38–0.66) | .000 |
28–<32 | 2.16 (1.26–3.71) | .005 | 1.76 (1.16–2.67) | .008 | 0.69 (0.57–0.84) | .000 |
32–<34 | 1.23 (0.75–2.02) | .42 | 1.07 (0.67–1.71) | .77 | 0.84 (0.69–1.03) | .09 |
34–35 | Reference | Reference | Reference | |||
Race/ethnicity | ||||||
White | Reference | Reference | Reference | |||
Black | 0.59 (0.34–1.03) | .06 | 0.7 (0.43–1.13) | .14 | 1.17 (0.94–1.45) | .16 |
Asian | 0.36 (0.09–1.36) | .13 | 0.72 (0.19–2.68) | .62 | 1.88 (1.04–3.43) | .04 |
Other/ Unknown | 0.92 (0.47–1.79) | .81 | 0.57 (0.33–1.00) | .05 | 1.39 (1.09–1.77) | .007 |
Hispanic | 1.15 (0.36–3.62) | .82 | 1.56 (0.66–3.69) | .31 | 092 (0.62–1.36) | .67 |
Male | 1.19 (0.8–1.76) | .39 | 0.86 (0.63–1.19) | .38 | 0.93 (0.81–1.08) | .35 |
Multiple gestation | 1.30 (0.86–1.97) | .22 | 0.73 (0.52–1.02) | .07 | 1.1 (0.94–1.27) | .23 |
Insurance group | ||||||
Private | Reference | Reference | Reference | |||
Any Medicaid | 1.08 (0.62–1.87) | .79 | 0.62 (0.39–0.97) | .04 | 1.19 (0.96–1.46) | .11 |
Any self-pay | 0.89 (0.51–1.54) | .67 | 1.01 (0.64–1.6) | .97 | 0.96 (0.78–1.17) | .67 |
Medical factors | ||||||
Chronic lung disease | 1.70 (0.52–5.55) | .38 | 2.59 (1.29–5.22) | .008 | 0.83 (0.62–1.12) | .22 |
Failure to thrive | 1.77 (0.65–4.83) | .26 | 1.87 (0.97–3.62) | .06 | 0.62 (0.47–0.82) | .001 |
Airway malacia | 2.07 (0.58–7.41) | .26 | 2.79 (1.24–6.3) | .01 | 0.75 (0.53–1.05) | .09 |
Feeding difficulties | 1.03 (0.66–1.61) | .89 | 1.3 (0.9–1.88) | .16 | 0.87 (0.74–1.03) | .10 |
Dysphagia | 0.57 (0.05–6.55) | .65 | 0.62 (0.09–4.08) | .62 | 1.06 (0.53–2.1) | .87 |
ALTE/apnea | 0.77 (0.47–1.25) | .29 | 0.95 (0.64–1.4) | .80 | 1.03 (0.86–1.22) | .78 |
Tube feeding | 1.67 (0.17–16.26) | .66 | 2.44 (0.55–10.8) | .24 | 0.55 (0.34–0.89) | .02 |
Supplemental oxygen | 0.53 (0.15–1.86) | .32 | 1.58 (0.53–4.33) | .38 | 0.76 (0.52–1.11) | .16 |
Reactive airway disease | 2.17 (1.09–4.3) | .03 | 1.67 (1.05–2.65) | .03 | 0.73 (0.6–0.89) | .002 |
HR, hazard ratio.
Time to discontinue all medications used a Cox proportional hazards model, where ratios <1 indicated longer use of medications, and ratios >1 indicated shorter use of medications compared with the reference category.